Follow
Chi-Yeh Chung
Chi-Yeh Chung
Verified email at pfizer.com
Title
Cited by
Cited by
Year
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
Nature communications 6 (1), 6170, 2015
2962015
Histone variants: emerging players in cancer biology
C Vardabasso, D Hasson, K Ratnakumar, CY Chung, LF Duarte, ...
Cellular and molecular life sciences 71, 379-404, 2014
1982014
Histone variant H2A. Z. 2 mediates proliferation and drug sensitivity of malignant melanoma
C Vardabasso, A Gaspar-Maia, D Hasson, S Pünzeler, D Valle-Garcia, ...
Molecular cell 59 (1), 75-88, 2015
1942015
Sox2 in the dermal papilla niche controls hair growth by fine-tuning BMP signaling in differentiating hair shaft progenitors
C Clavel, L Grisanti, R Zemla, A Rezza, R Barros, R Sennett, AR Mazloom, ...
Developmental cell 23 (5), 981-994, 2012
1622012
Single-cell transcriptomes distinguish stem cell state changes and lineage specification programs in early mammary gland development
RR Giraddi, CY Chung, RE Heinz, O Balcioglu, M Novotny, CL Trejo, ...
Cell reports 24 (6), 1653-1666. e7, 2018
1372018
Epigenetic and transcriptomic profiling of mammary gland development and tumor models disclose regulators of cell state plasticity
C Dravis, CY Chung, NK Lytle, J Herrera-Valdez, G Luna, CL Trejo, ...
Cancer cell 34 (3), 466-482. e6, 2018
1302018
Cbx8 acts non-canonically with Wdr5 to promote mammary tumorigenesis
CY Chung, Z Sun, G Mullokandov, A Bosch, ZA Qadeer, E Cihan, Z Rapp, ...
Cell reports 16 (2), 472-486, 2016
1032016
BMP4 sufficiency to induce choroid plexus epithelial fate from embryonic stem cell-derived neuroepithelial progenitors
M Watanabe, YJ Kang, LM Davies, S Meghpara, K Lau, CY Chung, ...
Journal of Neuroscience 32 (45), 15934-15945, 2012
812012
Single-cell chromatin analysis of mammary gland development reveals cell-state transcriptional regulators and lineage relationships
CY Chung, Z Ma, C Dravis, S Preissl, O Poirion, G Luna, X Hou, ...
Cell reports 29 (2), 495-510. e6, 2019
752019
Tuft cells inhibit pancreatic tumorigenesis in mice by producing prostaglandin D2
KE DelGiorno, CY Chung, V Vavinskaya, HC Maurer, SW Novak, NK Lytle, ...
Gastroenterology 159 (5), 1866-1881. e8, 2020
442020
Tuft cell formation reflects epithelial plasticity in pancreatic injury: implications for modeling human pancreatitis
KE DelGiorno, RF Naeem, L Fang, CY Chung, C Ramos, N Luhtala, ...
Frontiers in physiology 11, 88, 2020
442020
Stem cell determinant SOX9 promotes lineage plasticity and progression in basal-like breast cancer
JR Christin, C Wang, CY Chung, Y Liu, C Dravis, W Tang, MH Oktay, ...
Cell reports 31 (10), 2020
372020
Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer
N Bansal, K Petrie, R Christova, CY Chung, BA Leibovitch, L Howell, V Gil, ...
Oncotarget 6 (33), 34087, 2015
352015
SAM-competitive PRMT5 inhibitor PF-06939999 demonstrates antitumor activity in splicing dysregulated NSCLC with decreased liability of drug resistance
K Jensen-Pergakes, J Tatlock, KA Maegley, IJ McAlpine, M McTigue, ...
Molecular Cancer Therapeutics 21 (1), 3-15, 2022
342022
Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells
YJ Kwon, BA Leibovitch, N Bansal, L Pereira, CY Chung, EV Ariztia, ...
Oncotarget 8 (51), 88421, 2017
182017
Intrinsic and acquired drug resistance to LSD1 inhibitors in small cell lung cancer occurs through a TEAD4‐driven transcriptional state
W Yan, CY Chung, T Xie, M Ozeck, TC Nichols, J Frey, AR Udyavar, ...
Molecular Oncology 16 (6), 1309-1328, 2022
172022
MacroH2A histone variants modulate enhancer activity to repress oncogenic programs and cellular reprogramming
W Mohammed Ismail, A Mazzone, FG Ghiraldini, J Kaur, M Bains, ...
Communications Biology 6 (1), 215, 2023
72023
NR2F1 controls tumour cell dormancy via SOX9-and RARβ-driven quiescence programmes. Nat Commun. 2015; 6: 6170
MS Sosa, F Parikh, AG Maia, Y Estrada, A Bosch, P Bragado, E Ekpin, ...
7
Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer
S Sharma, CY Chung, S Uryu, J Petrovic, J Cao, A Rickard, N Nady, ...
Cell Chemical Biology 30 (10), 1191-1210. e20, 2023
62023
Single-Cell Transcriptomes Distinguish Stem Cell State Changes and Lineage Specification Programs in Early Mammary Gland Development. CellReports [Internet]. 2018 [cited 2020 …
RR Giraddi, CY Chung, RE Heinz, O Balcioglu, M Novotny, CL Trejo
4
The system can't perform the operation now. Try again later.
Articles 1–20